TAK-505 / Takeda - LARVOL DELTA

A Study of TAK-505 in Adults With Solid Tumors (clinicaltrials.gov) - P1/2 | N=151 | Not yet recruiting | Sponsor: Takeda

First-in-human • Monotherapy • New P1/2 trial • Colorectal Cancer • Gastric Cancer • Head and Neck Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck • ALK • BRAF • MSI • RET • ROS1